A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Alexander A. Khromykh(The University of Queensland), Nias Y. G. Peng(The University of Queensland), Fasséli Coulibaly(Australian Regenerative Medicine Institute), Daniel J. Rawle(QIMR Berghofer Medical Research Institute), Frederick Moore(Queensland Health), James R. Potter(The University of Queensland), Julian D. J. Sng(The University of Queensland), Jessica J. Harrison(The University of Queensland), Daniel Watterson(The University of Queensland), Mark Bettington(The University of Queensland), David A. Muller(Cornell University), Roy A. Hall(The University of Queensland), Stacey T. M. Cheung(The University of Queensland), Benjamin Liang(The University of Queensland), Alyssa T. Pyke(Queensland Health), Andreas Suhrbier(The University of Queensland), Yin Xiang Setoh(Takeda (Singapore)), Paul R. Young(Kent State University), Francisco J. Torres(The University of Queensland), Rhys Parry(The University of Queensland), Joshua M. Deerain(The University of Melbourne), Jason M. Mackenzie(Peter Doherty Institute), Joshua M. Hardy(The University of Melbourne), Morgan E. Freney(The University of Queensland), Naphak Modhiran(The University of Queensland), Darwin J. Da Costa Guevara(The University of Queensland), Xiaohui Wang(First Affiliated Hospital Zhejiang University), Christopher L. D. McMillan(The University of Queensland), Thuy T. Le(The University of Melbourne), Jody Hobson‐Peters(The University of Queensland)
Nature Communications
June 8, 2021
Cited by 177


Related Papers